Total Payments
$1,132
2024 Payments
$523.60
Companies
14
Transactions
48
Medicare Patients
11,464
Medicare Billing
$5.3M
Payment Breakdown by Category
Food & Beverage$1,132 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,132 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $338.79 | 15 | $0 (2024) |
| Genentech USA, Inc. | $164.32 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $127.36 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $95.54 | 5 | $0 (2024) |
| Iridex Corporation | $86.19 | 2 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $85.18 | 4 | $0 (2024) |
| Alcon Vision LLC | $67.51 | 4 | $0 (2024) |
| EYEVANCE PHARMACEUTICALS LLC | $42.62 | 2 | $0 (2022) |
| Allergan Inc. | $32.86 | 2 | $0 (2019) |
| TearLab Corp | $22.48 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $523.60 | 21 | ABBVIE INC. ($258.60) |
| 2023 | $212.53 | 10 | Regeneron Healthcare Solutions, Inc. ($68.15) |
| 2022 | $156.02 | 8 | EYEVANCE PHARMACEUTICALS LLC ($42.62) |
| 2021 | $48.93 | 3 | TearLab Corp ($22.48) |
| 2019 | $32.86 | 2 | Allergan Inc. ($32.86) |
| 2018 | $15.16 | 1 | Regeneron Healthcare Solutions, Inc. ($15.16) |
| 2017 | $142.70 | 3 | Genentech USA, Inc. ($127.42) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/15/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: EYE CARE | ||||||
| 10/09/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Ophthalmology | ||||||
| 07/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/18/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: EYE CARE | ||||||
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/14/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: EYE CARE | ||||||
| 05/14/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: EYE CARE | ||||||
| 05/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: EYE CARE | ||||||
| 05/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $31.55 | General |
| 04/24/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Ophthalmology | ||||||
| 04/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: EYE CARE | ||||||
| 04/09/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Ophthalmology | ||||||
| 04/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: EYE CARE | ||||||
| 03/27/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: EYE CARE | ||||||
| 03/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: EYE CARE | ||||||
| 02/27/2024 | Iridex Corporation | — | Food and Beverage | Cash or cash equivalent | $71.49 | General |
| 01/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: EYE CARE | ||||||
| 12/19/2023 | Iridex Corporation | — | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| 11/13/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Ophthalmology | ||||||
| 10/12/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $37.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/03/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,507 | 21,334 | $3.7M | $1.9M |
| 2022 | 18 | 3,173 | 7,864 | $3.1M | $1.7M |
| 2021 | 19 | 3,189 | 6,542 | $1.8M | $1.1M |
| 2020 | 16 | 1,595 | 2,927 | $743,925 | $502,168 |
Total Patients
11,464
Total Services
38,667
Medicare Billing
$5.3M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 181 | 1,549 | $2.3M | $1.1M | 46.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 61 | 13,204 | $562,920 | $383,058 | 68.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 857 | 1,410 | $152,776 | $93,508 | 61.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 240 | 1,070 | $178,940 | $91,331 | 51.0% |
| 92134 | Imaging of retina | Office | 2023 | 1,016 | 2,421 | $161,553 | $74,744 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 328 | 672 | $104,090 | $63,855 | 61.3% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 68 | 105 | $69,089 | $41,479 | 60.0% |
| 67220 | Destruction of vascular growth between retina and sclera by photocoagulation | Office | 2023 | 53 | 75 | $58,752 | $31,982 | 54.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 141 | 162 | $35,616 | $17,301 | 48.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 133 | 133 | $26,590 | $14,400 | 54.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 128 | 128 | $17,655 | $9,702 | 55.0% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2023 | 46 | 57 | $9,950 | $5,811 | 58.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 85 | 118 | $8,876 | $3,937 | 44.4% |
| 92250 | Photography of the retina | Office | 2023 | 92 | 120 | $8,724 | $3,303 | 37.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 25 | 56 | $5,580 | $3,044 | 54.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 40 | 40 | $777.12 | $425.83 | 54.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 13 | 14 | $886.78 | $351.38 | 39.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 179 | 1,760 | $2.3M | $1.3M | 54.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 237 | 1,083 | $183,077 | $92,962 | 50.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 353 | 747 | $114,048 | $72,227 | 63.3% |
| 92134 | Imaging of retina | Office | 2022 | 940 | 2,261 | $147,864 | $72,025 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 612 | 896 | $96,976 | $58,588 | 60.4% |
| 67210 | Destruction of growth of retina using a laser | Office | 2022 | 75 | 131 | $88,257 | $55,162 | 62.5% |
| 67220 | Destruction of vascular growth between retina and sclera by photocoagulation | Office | 2022 | 74 | 121 | $96,295 | $52,375 | 54.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 122 | 143 | $31,008 | $14,641 | 47.2% |
About Dr. Alexandre Gauthier, M.D
Dr. Alexandre Gauthier, M.D is a Ophthalmology healthcare provider based in Warrenton, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1710206057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexandre Gauthier, M.D has received a total of $1,132 in payments from pharmaceutical and medical device companies, with $523.60 received in 2024. These payments were reported across 48 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,132).
As a Medicare-enrolled provider, Gauthier has provided services to 11,464 Medicare beneficiaries, totaling 38,667 services with total Medicare billing of $5.3M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Warrenton, VA
- Active Since 05/26/2010
- Last Updated 03/07/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1710206057
Products in Payments
- OZURDEX (Drug) $154.31
- LUMIGAN (Drug) $147.41
- Lucentis (Biological) $127.42
- EYLEA HD (Biological) $96.92
- Izervay (Drug) $81.37
- XIPERE (Drug) $43.79
- TobraDex ST (Drug) $42.62
- Clareon (Device) $40.49
- EYLEA AFLIBERCEPT INJECTION (Biological) $30.44
- MIEBO (Drug) $23.29
- TearLab Osmolarity System (Device) $22.48
- XDEMVY (Drug) $20.40
- ALPHAGAN P (Drug) $19.75
- VUITY (Drug) $18.63
- VABYSMO (Drug) $18.48
- Vabysmo (Drug) $18.42
- VYZULTA (Drug) $18.10
- TYRVAYA (Drug) $15.11
- DAILIES (Device) $14.05
- LUXTURNA (Biological) $13.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Warrenton
Dr. Sam Mansour, Md, MD
Ophthalmology — Payments: $78,558
Ophthalmology $78,558
Dr. Marena Patronas, M.d, M.D
Ophthalmology — Payments: $2,510
Ophthalmology $2,510
Dr. Malkit Singh, Md Mpa, MD MPA
Ophthalmology — Payments: $1,653
Ophthalmology $1,653
Alessa Crossan, M.d, M.D
Ophthalmology — Payments: $1,280
Ophthalmology $1,280